BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5491934)

  • 21. Cardiac surgery in a patient with haemophilia A.
    Eren A; Friedl R; Hannekum A; Gulbins H
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):212-4. PubMed ID: 16639687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preoperative care and anesthesia in urological patients with chronic renal insufficiency].
    Kan DV; Burov NE; Korkus AA
    Eksp Khir Anesteziol; 1972; 17(2):59-61. PubMed ID: 5044670
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hepatitis A in patients with haemophilia A.
    Peerlinck K; Vermylen J
    Lancet; 1993 Jan; 341(8838):179. PubMed ID: 8093776
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia.
    O'Brien JR
    Proc R Soc Med; 1967 Mar; 60(3):243-4. PubMed ID: 6020147
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oral surgery in hemophilia patients].
    Mokhtari H; Roosendaal G; Koole R; Mauser-Bunschoten EP; van den Berg HM
    Ned Tijdschr Tandheelkd; 2003 Feb; 110(2):74-7. PubMed ID: 12621999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Previously untreated patients and recombinant factor VIII concentrate studies.
    Pasi KJ
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S29-32. PubMed ID: 9351534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successfull extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII].
    Marisavljević D; Glisić M; Elezović I; Popović A; Rolović Z
    Srp Arh Celok Lek; 1991; 119(11-12):338-42. PubMed ID: 17974380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preoperative examination of cardiovascular system in elderly and old urological patients].
    Bukaev IuN; Rumiantsev VB; Zadoev SA; Glukhova NS
    Urol Nefrol (Mosk); 1998; (1):27-9. PubMed ID: 9532942
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryoglobulinaemia in haemophilia.
    Lee CA; Kernoff PB; Peters DK
    Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1947-8. PubMed ID: 3924321
    [No Abstract]   [Full Text] [Related]  

  • 35. [Surgical and urological management of a patients with hemophilia A].
    Winckelmann G; Krauss H; Groh R; Gaca A; Matthes M
    Dtsch Med Wochenschr; 1969 Mar; 94(10):466-73 passim. PubMed ID: 5764888
    [No Abstract]   [Full Text] [Related]  

  • 36. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human parvovirus B19 infection in persons with haemophilia.
    Prowse C; Dow B; Pelly SJ; McIntosh E; Reading S; Lowe GD; Gibson B; Cachia P; Thomas A; Dennis R; Ludlam CA
    Thromb Haemost; 1998 Aug; 80(2):351. PubMed ID: 9716173
    [No Abstract]   [Full Text] [Related]  

  • 38. Cryoprecipitate in the management of haemophilia in Kenya.
    Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL
    East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053
    [No Abstract]   [Full Text] [Related]  

  • 39. Fracture neck of femur in haemophilia A - experience from a cohort of 11 patients from a tertiary centre in India.
    Lee VN; Srivastava A; Nithyananth M; Kumar P; Cherian VM; Viswabandya A; Mathews V; George B; Venkatesh K; Nair SC; Chandy M; Sundararaj GD
    Haemophilia; 2007 Jul; 13(4):391-4. PubMed ID: 17610554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.